IMDx to Develop Tests on Abbott's m2000 Platform

The tests covered by the agreement include assays for Clostridium difficile, vancomycin-resistant Enterococci; Group B Streptococci; Influenza A/Influenza B, and Herpes simplex virus types 1 and 2.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.